Tesla: Analysts Call For Q2 Earnings Per Share Of $1.83

Tesla (NASDAQ: TSLA) will be reporting its second quarter financial results on July 20 after markets close. Analysts have a consensus $883.15 12-month price target on the company, via a total of 45 analysts, with 11 analysts having strong buy ratings.

15 analysts meanwhile have buy ratings, 10 have hold ratings, 6 have sell ratings and the last 3 analysts have strong sells on the company. The street high comes from KGI Greater China with a $1,620 price target, and the lowest target sits at $67 from GLJ Research.

20 analysts have revenue estimates for the second quarter. The mean revenue estimate between all 20 analysts is $16.39 billion; this number is now flat year to date. The highest revenue estimate is $19.89 billion, while the lowest is $15.35 billion.

Onto EBITDA estimates, there are currently 8 analysts who have second-quarter EBITDA estimates. The mean is currently $3.52 billion, with this number coming in lower than at the start of the year. The street high estimate currently sits at $4.79 billion in EBITDA and the lowest is $2.6 billion.

Analysts estimate that quarterly earnings per share will come in at $1.83, which has come down and now is flat year to date. Street high is $3.00, and the lowest estimate is $1.11 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Building the $500M-a-Year Gold Mine | Victor Cantore – Amex Gold Mining

Building the Next 500,000-Ounce Gold Producer | Stephen Soock – Heliostar Metals

This Gold Explorer Is Making Its Biggest Bet | Brian Miller – Astra Exploration

Recommended

This Gold Discovery Just Keeps Getting Bigger | Roger Rosmus – Goliath Resources

Cardiol Expands MAVERIC Trial to Up to 150 Patients After Reaching Enrollment Target Early

Related News

Yamana Gold: BMO Reiterates $8 Price Target

On January 13th, Yamana Gold Inc. (TSX: YRI) announced its preliminary fourth quarter and full...

Sunday, January 16, 2022, 03:36:00 PM

Well Health: Consensus Price Target Climbs To $11.83 Following MyHealth Acquisition

WELL Health Technologies Corp. (TSX: WELL) this week announced that they would be acquiring MyHealth...

Thursday, June 10, 2021, 11:46:00 AM

Canaccord Genuity Initiates Coverage On Artemis Gold With C$13 Price Target

Canaccord Genuity initiated coverage on Artemis Gold (TSXV: ARTG) this morning with a Speculative Buy...

Thursday, September 10, 2020, 03:00:12 PM

WeedMD: Canaccord Reiterates Price Target After Earnings

WeedMD (TSXV: WMD) reported their first-quarter financials of 2021 on June 29th. The company reported...

Thursday, July 1, 2021, 03:09:00 PM

Green Thumb: Canaccord Raises Price Target To $52 Following Q4 Results

On March 17th, Green Thumb Industries (CSE: GTII) reported their fourth quarter and year end...

Saturday, March 20, 2021, 02:41:00 PM